Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 940-942

  Langford, Melanie L ^a   Hasim, Sahar ^a   Nickerson, Kenneth W ^a   Atkin, Audrey L ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOL;

ARTICLE; CANDIDA ALBICANS; CELL DENSITY; CELL SIZE; CULTURE MEDIUM; DRUG ACTIVITY; DRUG SENSITIVITY; DRUG TOLERANCE; FUNGUS GROWTH; INOCULATION; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FARNESOL; GENE EXPRESSION REGULATION, FUNGAL; TEMPERATURE;

EID: 75749097655     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01214-09     Document Type: Article

References (17)

1. Aspedon, A., and K. W. Nickerson. 1993. A two-part energy burden imposed by growth of Enterobacter cloacae and Escherichia coli in sodium dodecyl sulfate. Can. J. Microbiol. 39:555-561.
2. Davis-Hanna, A., A. E. Piispanen, L. I. Stateva, and D. A. Hogan. 2008. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol. Microbiol. 67:47-62.
3. Dumitru, R., J. M. Hornby, and K. W. Nickerson. 2004. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob. Agents Chemother. 48:2350-2354.
4. Dumitru, R., D. H. Navarathna, C. P. Semighini, C. G. Elowsky, R. V. Dumitru, D. Dignard, M. Whiteway, A. L. Atkin, and K. W. Nickerson. 2007. In vivo and in vitro anaerobic mating in Candida albicans. Eukaryot. Cell 6:465-472.
5. Gibson, J., A. Sood, and D. A. Hogan. 2009. Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 75:504-513.
6. Hisajima, T., N. Maruyama, Y. Tanabe, H. Ishibashi, T. Yamada, K. Makimura, Y. Nishiyama, K. Funakoshi, H. Oshima, and S. Abe. 2008. Protective effects of farnesol against oral candidiasis in mice. Microbiol. Immunol. 52:327-333.
7. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
8. Jabra-Rizk, M. A., M. Shirtliff, C. James, and T. Meiller. 2006. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res. 6:1063-1073.
9. Kebaara, B. W., M. L. Langford, D. H. Navarathna, R. Dumitru, K. W. Nickerson, and A. L. Atkin. 2008. Candida albicans Tup1 is involved in farnesolmediated inhibition of filamentous-growth induction. Eukaryot. Cell 7:980-987.
10. Langford, M. L., A. L. Atkin, and K. W. Nickerson. 2009. Cellular interactions of farnesol, a quorum sensing molecule produced by Candida albicans. Fut. Microbiol. 4:1353-1362.
11. Mosel, D. D., R. Dumitru, J. M. Hornby, A. L. Atkin, and K. W. Nickerson. 2005. Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl. Environ. Biol. 71:4938-4940.
12. Navarathna, D. H., J. M. Hornby, N. Hoerrmann, A. M. Parkhurst, G. E. Duhamel, and K. W. Nickerson. 2005. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis. J. Antimicrob. Chemother. 56:1156-1159.
13. Navarathna, D. H., J. M. Hornby, N. Krishnan, A. Parkhurst, G. E. Duhamel, and K. W. Nickerson. 2007. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect. Immun. 75:1609-1618.
14. Rajagopal, S., N. Eis, M. Bhattacharya, and K. W. Nickerson. 2003. Membrane-derived oligosaccharides (MDOs) are essential for sodium dodecyl sulfate resistance in Escherichia coli. FEMS Microbiol. Lett. 223:25-31.
15. Ramage, G., S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
16. Shirtliff, M. E., B. P. Krom, R. A. Meijering, B. M. Peters, J. Zhu, M. A. Scheper, M. L. Harris, and M. A. Jabra-Rizk. 2009. Farnesol-induced apoptosis in Candida albicans. Antimicrob. Agents Chemother. 53:2392-2401.
17. Uppuluri, P., S. Mekala, and W. L. Chaffin. 2007. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. Yeast 24:681-693.